For example, before seeing a specialist, 9622 of 12 867 patients (74.8%) with diabetes and hypertension used an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, while in the 6 months after seeing an FFS specialists, 6426 patients (89.3%) (95% CI, 85.2-93.6) used one of these drugs and, in the 6 months after seeing a salary-based specialist, 6441 patients (85.1%) (95% CI, 81.1-89.3) did. This evidence concerns the gene ACE and hypertensive disorder.